Showing results (151-160 of 4,238) with videos related to
Sort By:
Pageof 424
Journal for Immunotherapy of Cancer|May 1, 2019
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse modelsWeiqing Jing, Donna McAllister, Emily P Vonderhaar, et al.Journal for Immunotherapy of Cancer|September 20, 2018
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancerJason M Redman, Seth M Steinberg, James L GulleyJournal for Immunotherapy of Cancer|September 27, 2018
Correction to: CART cells are prone to Fas- and DR5-mediated cell deathBenjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.Journal for Immunotherapy of Cancer|May 18, 2019
Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinomaSehhoon Park, Je-Gun Joung, Yang Won Min, et al.Journal for Immunotherapy of Cancer|April 11, 2019
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialXiaotong Li, Sarah Warren, Vasiliki Pelekanou, et al.Journal for Immunotherapy of Cancer|May 4, 2019
Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reportsRoberta Noseda, Raffaela Bertoli, Laura Müller, et al.Journal for Immunotherapy of Cancer|May 11, 2018
A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case reportWon Jin Ho, Lisa Rooper, Sarah Sagorsky, et al.Journal for Immunotherapy of Cancer|May 12, 2018
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD AndersonYinghong Wang, Hamzah Abu-Sbeih, Emily Mao, et al.Journal for Immunotherapy of Cancer|July 18, 2018
Sick sinus syndrome associated with anti-programmed cell death-1Chien-Yi Hsu, Yu-Wen Su, San-Chi ChenJournal for Immunotherapy of Cancer|October 7, 2021
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapyPascale Lejeune, Véronique Cruciani, Axel Berg-Larsen, et al.Pageof 424